ProMIS Neurosciences Inc PMN

Pretty simple answer

[retiredcop]

Pretty simple answer.. STOP focusing on getting rid of the plaque... work on those oligomers 

https://www.alzforum.org/news/conference-coverage/gantenerumab-mystery-how-did-it-lose-potency-phase-3

[M101]

Yes, exactly. So then the question for Promis management is whether there is any ROI in promoting this idea, and evidence suggests they've decided that no, not beyond the normal shareholder updates so not for the purpose of attracting new investors.  Which suggests they are quite satisfied with the status quo leaving the share price in the cellar for now, and anyway no amount of money

[G1945V]

"Pretty simple answer"  YES! Go clinical once and for all, and fast, before PMN goes bust. Remember, we're on NASDAQ already. That doesn't seem to be helping the SPP in any way, thus far! G1945V

[bball67]

I spoke with Nick about two weeks ago. He let me know that there would be a sizeable management prescence at the JP Morgan Heathcare Conference Jan 9-12. He said it included the CEO. It sounded like they would be marketing the story and would be busy. 

[BottomBroker]

Who is Nick? I assume he's part of PMN management? Did he happen to mention when the IND might be filed and when trials would start? Because that's the ONLY thing that will have a lasting, positive effect on the share price, IMO. 

[bball67]

Nick is the legacy investor relations guy. He will be at the conference. They do have a new third party investor relations person who just works with institutional investors. You might not think this is important work, but it is. 

[BottomBroker]

So he didn't say when the IND would be filed. Or when trials would start.  But they'll be hobnobbing at the conference this year. Again.  Can't wait.

[M101]

Whoopie, attending that healthcare conference, which they do every year. Oh and they'll be busy too (as opposed to?), well that inspires confidence.  And they pay Nick to blow off legacy investors with this garbage.